James Lederer

Company: Alloplex Biotherapeutics Inc.

Job title: Chief Scientific Officer

Seminars:

Examining the Mechanism of Action of Signalling of CAR-Engineered Gamma Delta T Cells to Enhance Design 10:00 am

Understanding the mechanism of recruitment to sites to boost the frequency of tumor resident gamma delta cells Interrogating the mechanism of CAR signalling in a gamma delta construct Boosting the activation and cytotoxicity at the site through combination therapy and CAR design Developing pharmacodynamic markers for cellular therapy treatmentRead more

day: Conference Day Two